New pill combo aims to fight advanced cancers that stopped responding to prior therapies
Disease control
Recruiting now
This study tests two oral drugs, AMXT 1501 and DFMO, given alongside standard treatments for people with advanced solid tumors (breast cancer or melanoma) that have worsened after prior therapies. The goal is to find a safe dose and see if the combination helps shrink tumors or s…
Phase: PHASE1, PHASE2 • Sponsor: Aminex Therapeutics, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC